Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

Deniz Tural,Suheyla Serdengecti,Fuat Demirelli,Tülin Öztürk,Şennur İlvan,Hande Turna,Mustafa Ozguroglu,Evin Büyükünal

Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

2014

Deniz Tural
Suheyla Serdengecti
Fuat Demirelli
Tülin Öztürk
Şennur İlvan
Hande Turna
Mustafa Ozguroglu
Evin Büyükünal

Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

Keywords:

Medicine
Immunology
PTEN
Pathology
PI3K/AKT/mTOR pathway
Trastuzumab
Elafin
Clinical significance
Metastatic breast cancer
disease free survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations